| 6.68 Delayed Data As of Jan 18 |  +0.20 / +3.09%Today’s Change | 3.75 Today|||52-Week Range 18.52 | +17.40% Year-to-Date |
| Why Marijuana ETF is on a High in 2019 Jan 16 / Zacks.com - Paid Partner Content |
| Previous close | 6.48 |
| Today’s open | 6.55 |
| Day’s range | 6.24 - 6.70 |
| Volume | 3,951,622 |
| Average volume (3 months) | 5,443,288 |
| Market cap | $2.2B |
| Earnings growth (last year) | +368.54% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +87.91% |
| P/E ratio | 25.3 |
| Price/Sales | 50.76 |
| Price/Book | 2.07 |
| Today’s change | Today’s % change | |
|---|---|---|
| USNAUSANA Health Science... | +2.34 | +2.01% |
| ARGXargenx SE | -1.05 | -1.02% |
| CRONCronos Group Inc | +1.24 | +9.08% |
| LJPCLa Jolla Pharmaceuti... | +0.05 | +0.80% |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $29.0M |
| Annual profit (last year) | $23.2M |
| Net profit margin | 79.77% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Victor Neufeld |
President Jakob Ripshtein |
Corporate headquarters Leamington, Ontario |
